A mechanistic study reveals that RBPMS suppresses bladder cancer cell migration by regulating alternative splicing of ANKRD10, which modulates MYC pathway activity through ANKRD10-2’s function as a transcriptional coactivator. Here, MYC is linked to urinary bladder carcinoma.